HK Stock Market Move | GIANT BIOGENE (02367) fell by more than 5% again, Double Eleven online shopping promotion started early, market will focus on the sales performance of KF94 masks.

GIANT BIOGENE (02367) fell by more than 5% again, dropping 5.33% to HK$50.6 as of the time of publication, with a trading volume of HK$6.28 billion. In terms of news, the 2025 Double 11 e-commerce promotion has already started early. Huatai previously pointed out that under the background of certain external factors affecting the 25Q2, GIANT BIOGENE's first-half revenue and profit can still double, and the profitability remains relatively stable, demonstrating brand strength and performance resilience. With the approaching peak season of Double 11, the company's brand promotion and influencer activities are expected to gradually resume and drive the company's growth acceleration in H2. It is worth noting that Bloomage Biotechnology Corporation Limited announced at the end of September that it had conducted testing on related products of various enterprises in collaboration with the National Institute of Metrology and other third-party testing institutions. The results of dozens of tests showed that the amount of recombinant collagen protein added in the related products did not meet the standards. Bloomage Biotechnology Corporation Limited stated, "Dozens of test reports have been submitted to the National Medical Products Administration." Analysts said that KUFUMEI had a disappointing performance in this year's 618 e-commerce promotion, and the market will focus on the e-commerce sales performance of KUFUMEI during the Double 11 period.